Does Humana Cover Metformin?

Where Metformin Falls on Humana Formularies

Generic metformin hydrochloride sits on Tier 1 of most Humana Medicare Part D and Medicare Advantage Prescription Drug (MAPD) plans. Tier 1 is reserved for preferred generics, the lowest cost-sharing category available. According to the Centers for Medicare & Medicaid Services (CMS), metformin has appeared on the Medicare Model Formulary reference list continuously since the program launched in 2006 1.

Humana publishes plan-specific formularies each year. While exact cost-sharing varies by plan ID and region, the pattern is consistent: immediate-release metformin 500 mg, 850 mg, and 1 to 000 mg tablets are Tier 1. Extended-release (ER) formulations, including metformin ER 500 mg and 750 mg, usually land on Tier 1 as well, though certain Humana plans place them on Tier 2 (non-preferred generic).

Brand-name Glucophage and Glucophage XR are rarely stocked in Humana formularies at a favorable tier. If they appear at all, they occupy Tier 3 (preferred brand) or the non-preferred brand tier, pushing copays above $40 per fill. The American Diabetes Association (ADA) 2024 Standards of Care states, "Metformin is the preferred initial pharmacologic agent for type 2 diabetes when not contraindicated" 2. Because the generic is therapeutically equivalent, Humana and other payers default to it.

Typical Copays and Out-of-Pocket Costs

Most Humana Medicare Part D enrollees pay $0 to $15 for a 30-day supply of Tier 1 metformin at a preferred pharmacy. That figure can drop to $0 on plans that offer a $0-copay generic benefit during the initial coverage phase. A 2023 Kaiser Family Foundation analysis found that the median Tier 1 copay across all Part D plans was $2, and metformin ranked among the ten most-dispensed generics in the program 3.

For Humana commercial (employer-sponsored) plans, cost-sharing depends on the employer's benefit design. Typical ranges:

• Tier 1 copay: $5 to $15 per 30-day fill
• Coinsurance plans: 10 to 20 percent of the negotiated price, often under $5
• High-deductible health plans (HDHPs): full cost until the deductible is met, but generic metformin rarely exceeds $10 to $20 at retail

Mail-order pharmacy fills (90-day supply) usually cut per-unit cost. Humana's CenterWell Pharmacy (formerly Humana Pharmacy) offers home delivery with preferred pricing. A 90-day fill of metformin 1 to 000 mg through CenterWell typically costs $0 to $12 on Medicare plans.

The Inflation Reduction Act of 2022 introduced an annual out-of-pocket cap for Medicare Part D. Starting in 2025, that cap is $2,000 per year for all covered drugs 4. Metformin fills count toward this maximum. For members taking multiple medications, this cap provides a hard ceiling on yearly drug spending.

Prior Authorization and Quantity Limits

Standard metformin tablets do not require prior authorization on Humana plans. This applies to both immediate-release and extended-release versions. No step therapy protocols exist for first-line metformin, meaning your prescriber does not need to document failure of another drug before Humana approves coverage.

Quantity limits align with clinical dosing guidelines. The FDA-approved maximum daily dose of metformin immediate-release is 2 to 550 mg (typically three 850 mg tablets or two-and-a-half 1 to 000 mg tablets), while the extended-release maximum is 2 to 000 mg per day 5. Humana's quantity limits generally match these thresholds, so fills within standard dosing ranges process without manual intervention.

One exception: metformin oral solution (Riomet) may require prior authorization because it costs significantly more than tablets. Humana may request documentation of dysphagia or another clinical reason before covering the liquid formulation.

How to Check Your Specific Humana Plan

Formulary details vary across Humana's 400-plus plan options. Three quick ways to verify your coverage:

1. Humana's online formulary tool. Log in to Humana.com, manage to "Pharmacy," and search for metformin. The tool returns your plan's tier, copay, and any restrictions.

2. Call the number on your member ID card. A pharmacy benefits representative can confirm tier placement, preferred pharmacy networks, and mail-order options.

3. Ask your pharmacist to run a test claim. This returns the exact copay before you commit to filling.

The ADA recommends that clinicians "consider cost when selecting glucose-lowering therapy" 2. Generic metformin is one of the least expensive prescription medications in the United States. GoodRx data from 2024 showed an average retail cash price of $4 to $12 for a 30-day supply of metformin 500 mg twice daily, even without insurance 6.

Metformin Extended-Release vs. Immediate-Release Coverage

Both formulations are covered, but tier placement can differ. Immediate-release metformin (taken two to three times daily) almost always sits on Tier 1 across all Humana plans. Extended-release metformin (taken once daily) is Tier 1 on most plans, though a subset of Humana MAPD plans place it on Tier 2.

The clinical difference matters for adherence. A 2017 Cochrane review of 37 trials (N=3,679) found that extended-release metformin produced equivalent HbA1c reduction compared to immediate-release (mean difference 0.01%, 95% CI: −0.09 to 0.10) while reducing gastrointestinal side effects 7. If your plan charges a higher copay for ER, ask your prescriber whether the GI benefit justifies the cost difference. For many patients, the answer is yes.

Dr. Silvio Inzucchi, Professor of Medicine at Yale School of Medicine, has noted: "Extended-release metformin can meaningfully improve GI tolerability, which translates to better long-term adherence in patients who would otherwise discontinue the drug" 8. If GI side effects have caused you to stop metformin in the past, the ER formulation under your Humana plan may solve that problem for a minimal copay increase.

Metformin for Off-Label Uses and Humana Coverage

Metformin is FDA-approved for type 2 diabetes in adults and children aged 10 and older. Prescribers also use it off-label for polycystic ovary syndrome (PCOS), prediabetes, and weight management. The question is whether Humana covers these off-label uses.

The short answer: Humana covers the drug, not the diagnosis. When your pharmacy processes a metformin claim, the plan adjudicates based on the medication and quantity, not the ICD-10 code on the prescription. In practice, metformin prescribed for PCOS or prediabetes fills without issue on Humana formularies because the system sees a Tier 1 generic and approves it.

The Diabetes Prevention Program (DPP) trial, one of the largest prevention studies ever conducted (N=3,234), demonstrated that metformin 850 mg twice daily reduced type 2 diabetes incidence by 31% over 2.8 years compared to placebo 9. A 15-year follow-up confirmed sustained benefit 10. The USPSTF and ADA both recognize metformin as an option for diabetes prevention in high-risk adults 11.

Emerging research into metformin's potential longevity benefits centers on the TAME (Targeting Aging with Metformin) trial, a multi-site study designed to test whether metformin delays age-related diseases in non-diabetic adults aged 65 to 79. While TAME results are pending, the trial's design reflects growing clinical interest in metformin beyond glycemic control 12.

What to Do If Humana Denies a Metformin Claim

Denials for standard generic metformin are rare but not impossible. Common triggers include:

• Filling at an out-of-network pharmacy. Humana preferred pharmacy networks offer the lowest copays. Out-of-network fills may be denied entirely on some plans or processed at a much higher cost-sharing level.
• Exceeding quantity limits. If a prescriber writes for a dose above 2 to 550 mg/day (immediate-release) or 2 to 000 mg/day (extended-release), the claim may reject.
• Requesting brand-name Glucophage without clinical justification. Humana may deny brand coverage when a generic equivalent exists.

If you receive a denial, you have appeal rights. Humana's standard appeal process follows CMS timelines for Medicare plans: 7 calendar days for a standard redetermination, 72 hours for an expedited appeal. Your prescriber can submit a coverage determination request through Humana's provider portal or by fax.

Lowering Your Metformin Cost Even Further

Even with Humana coverage, a few strategies can reduce costs to $0:

Use a preferred pharmacy. Humana contracts with specific pharmacy chains (Walgreens, CVS, Walmart, and CenterWell, among others) as preferred partners. Tier 1 copays at preferred pharmacies are typically $2 to $5 less than at non-preferred locations.

Switch to mail order. CenterWell Pharmacy handles Humana's mail-order benefits. A 90-day metformin supply by mail often has a lower copay than three separate 30-day retail fills.

Check for $0-copay plan options. Some Humana Medicare Advantage plans advertise $0 copays for all Tier 1 generics during the initial coverage phase. During annual enrollment (October 15 to December 7), compare plans using the Medicare Plan Finder tool to identify these options.

Apply manufacturer or pharmacy discount programs. Though rarely necessary for a drug this inexpensive, programs like Walmart's $4 generic list and Mark Cuban's Cost Plus Drugs offer metformin at minimal cash prices. These can serve as a backup if network issues arise.

The Endocrine Society's 2019 clinical practice guideline states: "Cost and insurance coverage should be considered in selecting pharmacotherapy, as even small copayments can affect adherence in vulnerable populations" 13. For a drug as affordable as metformin, the goal is eliminating cost as a barrier entirely.

Safety Monitoring Humana May Require

While Humana does not gate metformin behind prior authorization, safe prescribing requires baseline and periodic lab monitoring. The FDA label recommends checking estimated glomerular filtration rate (eGFR) before starting metformin and at least annually thereafter 5.

Current FDA guidance:

• eGFR ≥45 mL/min/1.73 m²: No dose adjustment needed
• eGFR 30 to 44: Metformin may be initiated at a reduced dose or continued at reduced dose with closer monitoring
• eGFR <30: Metformin is contraindicated

Vitamin B12 deficiency is another monitoring consideration. A sub-analysis of the DPP Outcomes Study found that long-term metformin use (median 9 years) was associated with a 13% higher prevalence of B12 deficiency compared to placebo 14. The ADA recommends periodic B12 measurement in patients on chronic metformin therapy, particularly those with anemia or peripheral neuropathy 2. Humana covers the B12 blood test as part of standard lab benefits under both Medicare and commercial plans.